EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 409 filers reported holding EXELIXIS INC in Q2 2024. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $539,280 | -5.3% | 24,000 | 0.0% | 0.04% | -6.7% |
Q1 2024 | $569,520 | -1.9% | 24,000 | -0.8% | 0.04% | -4.3% |
Q4 2023 | $580,558 | +9.8% | 24,200 | 0.0% | 0.05% | -2.1% |
Q3 2023 | $528,770 | +4.8% | 24,200 | -6.9% | 0.05% | +11.6% |
Q1 2023 | $504,660 | +21.0% | 26,000 | 0.0% | 0.04% | +22.9% |
Q4 2022 | $417,040 | +4.0% | 26,000 | +1.6% | 0.04% | -2.8% |
Q3 2022 | $401,000 | -24.8% | 25,600 | 0.0% | 0.04% | -16.3% |
Q2 2022 | $533,000 | +3231.2% | 25,600 | +3557.1% | 0.04% | +4200.0% |
Q1 2022 | $16,000 | -97.3% | 700 | -97.9% | 0.00% | -97.5% |
Q4 2021 | $602,000 | -21.8% | 32,900 | -9.6% | 0.04% | -32.2% |
Q3 2021 | $770,000 | +10900.0% | 36,400 | +9000.0% | 0.06% | +5800.0% |
Q4 2019 | $7,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $7,000 | -22.2% | 400 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $9,000 | -10.0% | 400 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $10,000 | -99.3% | 400 | -99.3% | 0.00% | -99.6% |
Q3 2017 | $1,403,000 | -1.6% | 57,900 | 0.0% | 0.24% | -15.4% |
Q2 2017 | $1,426,000 | -0.1% | 57,900 | -12.1% | 0.28% | -1.8% |
Q1 2017 | $1,428,000 | -87.7% | 65,900 | -53.5% | 0.28% | +29.1% |
Q4 2016 | $11,628,000 | +15828.8% | 141,800 | +2387.7% | 0.22% | +1057.9% |
Q3 2016 | $73,000 | – | 5,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |